Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab)

• Catalog Number: orb1806333
• Category: Antibodies
• Description: Anti-IL-6Ra / CD126 Reference Antibody is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.38 kDa.
• Target: IL-6Ra / CD126
• Clonality: Monoclonal
• Isotype: IgG
• Conjugation: Unconjugated
• Reactivity: Human
• Buffer/Preservatives: 100 mM Pro-Ac 20 mM Arg pH 5.0
• Purity: > 95%
• MW: 145.38 kDa
• Tested applications: ELISA, FA, FACS, Kinetics
• Endotoxins: < 1 EU/mg
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab)is more than 95% ;determined by SEC-HPLC.

Human IL-6R CHOs cells were stained with Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab) and negative control protein respectively; washed and then followed by PE and analyzed with FACS; EC801=0.4525 nM.

Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab)-induced FACS Blocking activity was evaluated using Human IL-6R CHO cells. The IC50 was approximately 1.303nM.